Original articleLevels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients
Introduction
Synaptic abnormalities may be involved in various sensory processing deficits associated with schizophrenia (Feinberg 1982). Electron microscopy studies have revealed ultrastructural changes in the synaptic organization of some brain regions of schizophrenic patients Miyakawa et al 1972, Ong and Garey 1993, Soustek 1989. Consistent with these data are biochemical findings indicating that region, age, and gene-specific abnormalities in expression of some synaptic proteins may be present in brains of schizophrenic patients. These studies have shown a pattern of synaptic protein disregulation with the levels of different synaptic proteins increased, decreased, or unchanged in different brain regions Browning et al 1993, Eastwood et al 1995, Eastwood and Harrison 1995, Glantz and Lewis 1997, Karson et al 1999, Thompson et al 1998.
In one series of studies increased concentrations of synaptophysin, as well as two other synaptic proteins (SNAP-25 and syntaxin), were revealed in cingulate cortex from a group of chronically hospitalized elderly schizophrenic patients (Gabriel et al 1997). A subsequent mRNA study in the same cohort of elderly schizophrenic patients provided further evidence that the expression of synaptic protein genes may be increased in some cortical regions of schizophrenic patients, but only in a subgroup of patients younger than 75 years (Tcherepanov and Sokolov 1997). Levels of mRNAs encoding three synaptic vesicle-associated proteins (synaptophysin, synapsin 1A, and synapsin 1B) were increased in the temporal cortex (Brodmann’s areas 21 and 22) of 52–73-year-old schizophrenic patients, compared to age matched control subjects, and declined significantly with age in schizophrenic patients, but not in control subjects. Coordinated age-associated alterations in expression of mRNAs encoding three major synaptic proteins (synaptophysin and synapsin 1A and synapsin 1B) were hypothesized to indicate overall age-related alterations in synaptic function in the temporal cortex of elderly schizophrenic patients (Tcherepanov and Sokolov 1997). It remains unclear, however, whether these alterations reflect overall abnormalities in synaptic density/activity or whether they are restricted to some specific synaptic functions or structures. For example, synaptophysin and synapsin 1 are localized solely to synaptic vesicles; thus, changes in their expression may reflect abnormalities in the number of synaptic vesicles per synapse rather than in the number of synapses.
One way to address these questions is to examine expression of other synaptic protein genes in brains of schizophrenic patients. Different synaptic proteins have different functions and localization in nerve terminals (synaptic vesicles or synaptic plasma membrane) and are differentially expressed in different neurons Jahn and Sudhof 1994, Oyler et al 1989, Sudhof 1995, Ullrich and Sudhof 1995. Therefore, differential alterations of different synaptic protein genes may reveal abnormalities in a specific synaptic function/structure and in specific subclasses of synapses. Alternatively, similar abnormalities in expression of many synaptic protein genes may indicate a general failure of synaptic function or a generalized reduction in synaptic specializations.
This study used measurements of mRNAs encoding four synaptic vesicle proteins (synaptotagmin I [p65], rab3a, synaptobrevin 1, synaptobrevin 2) and two synaptic plasma membrane proteins (syntaxin 1A and SNAP-25) to address the question of whether levels of these synaptic protein mRNAs were differentially or uniformly altered in elderly schizophrenic patients who had previously been found to have abnormal levels of some other synaptic protein mRNAs and synaptic proteins Gabriel et al 1997, Tcherepanov and Sokolov 1997. The superior temporal gyrus was chosen for study because of multiple studies showing structural abnormalities in this region in schizophrenia and suggesting a role for this region in the mediation of thought disorders and auditory hallucinations Barta et al 1997, Hirayasu et al 1998, Levitan et al 1999, Menon et al 1995, Nestor et al 1993, Pearlson 1997, Pearlson et al 1996, Penfield and Perot 1963, Ross and Pearlson 1986, Shenton et al 1992.
Section snippets
Patients
Postmortem brain specimens derived from elderly chronically institutionalized schizophrenic patients (n = 14) and normal elderly control subjects (n = 9) were obtained through the Schizophrenia Brain Bank of the Department of Psychiatry at the Mount Sinai School of Medicine, New York. Each case satisfied DSM-III-R criteria for schizophrenia. Eight of the 14 schizophrenic patients had been assessed and diagnosed antemortem within 18 months of death by a team of research psychiatrists; the
Age-related differences between schizophrenic patients and control subjects
Levels of mRNAs encoding three synaptic vesicle proteins—synaptotagmin 1, rab3a, and synaptobrevin 1 (measured as ratios to β-actin mRNA)—in the left superior temporal gyrus of schizophrenic patients correlated negatively and significantly with the age of subjects at time of death (−.692 <r < −.517, .003 <p < .03; Figure 2). Similarly, there were significant negative correlations between age of schizophrenic patients and levels of mRNAs encoding the synaptic plasma membrane proteins—syntaxin
Discussion
This study demonstrates that levels of mRNAs encoding three synaptic vesicle proteins (synaptotagmin 1, rab3a, and synaptobrevin 1) and two synaptic plasma membrane proteins (SNAP-25 and syntaxin 1A) decline significantly with age in the left superior temporal gyrus (BA22) of elderly schizophrenic patients. By contrast, no significant decreases with age were found in age-matched elderly control subjects. The levels of synaptic protein mRNAs in schizophrenic patients younger than 79.5 years were
Acknowledgements
This work was supported in part by MHCRC (NIH R2NH56083).
The authors gratefully acknowledge Drs. D. Perl and D. Purohit for their neuropathological characterization of the cases studied, and Drs. M. Davidson and P. Powchik for antemortem assessment of schizophrenic cases. We thank Dr. J. Schmeidler for his helpful comments on the statistical analysis.
A preliminary report on the work described here was presented at the Society of Biological Psychiatry Meeting in San Diego, CA, May 1997.
References (65)
- et al.
Structures and chromosomal localizations of two human genes encoding synaptobrevins 1 and 2
J Biol Chem
(1990) - et al.
Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
Biol Psychiatry
(1993) - et al.
Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
Neuroscience
(1995) - et al.
Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
Neuroscience
(1995) SchizophreniaCaused by a fault in programmed synaptic elimination during adolescence?
J Psychiatr Res
(1982)- et al.
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studiesSelective mRNA vulnerability and comparison with their encoded proteins
Neurosci Lett
(1995) - et al.
Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR
J Neurosci Methods
(1997) - et al.
Sutperior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia
Biol Psychiatry
(1999) - et al.
Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty
Mol Cell Neurosci
(1994) - et al.
Synaptic core complex of synaptobrevin, syntaxin, and SNAP25 forms high affinity α-SNAP binding site
J Biol Chem
(1995)
Posterior superior temporal gyrus in schizophreniaGrey matter changes and clinical correlates
Schizophr Res
Ultrastructural features of biopsied temporal cortex (area 38) in a case of schizophrenia
Schizophr Res
Superior temporal gyrus and planum temporale in schizophreniaA selective review
Prog Neuropsychopharmacol Biol Psychiatry
SchizophreniaA disease of heteromodal association cortex?
Neuropsychopharmacology
Structural and functional conservation of synaptotagmin (p65) in Drosophila and humans
J Biol Chem
Specificity and regulation of a synaptic vesicle docking complex
Neuron
Synaptotagmin-syntaxin interactionThe C2 domain as a Ca2+-dependent electrostatic switch
Neuron
Tissue-specific expression of the gene for type I procollagen (COL1A1) in transgenic mice. Only 476 base pairs of the promoter are required if collagen genes are used as promoters
J Biol Chem
Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia
Biol Psychiatry
Differential distributions of novel synaptotagminsComparison to synapsins
Neuropharmacology
The human rab genes encode a family of gtp-binding proteins related to yeast YPT1 and SEC4 products involved in secretion
J Biol Chem
Cloning and sequence analysis of a cDNA encoding human syntaxin 1A, a polypeptide essential for exocytosis
Gene
Planum temporale asymmetry reversal in schizophreniaReplication and relationship to gray matter abnormalities
Am J Psychiatry
Pre- and postmortem influences on brain RNA
J Neurochem
Closure of the Newman-Keuls multiple comparison procedure
J Am Stat Assoc
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal Biochem
Appendix
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients
Am J Psychiatry
Increased concentrations of presynaptic proteins in the cingulate cortex of schizophrenics
Arch Gen Psychiatry
The small GTP-binding protein Rab3a regulates a late step in synaptic vesicle fusion
Nature
Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia
Arch Gen Psychiatry
Synaptic vesicle membrane fusion complexAction of clostridial neurotoxins on assembly
EMBO J
Cited by (72)
Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes – A recognizable clinical phenotype
2021, European Journal of Paediatric NeurologyCitation Excerpt :VAMP1, as a part of the SNARE complex is required for the fusion of Aβ containing vesicles with presynaptic membrane and hence crucial in Aβ exocytosis. VAMP1 levels have been found to be reduced in superior temporal gyrus of schizophrenic patients and a null mutation of VAMP1 is also associated with lethal wasting and early death in a mouse model [17,18]. Bourassa et al., in 2012 reported a common heterozygous VAMP1 mutation in 50 patients from three multigenerational Newfoundland (Canada) families, affected with dominantly inherited hereditary spastic ataxia (HSA).
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
2020, IBRO ReportsCitation Excerpt :Synaptosomal-associated protein (SNAP)-25 and synaptotagmin (SYT)1 are situated in synaptic terminals of nerve cells, and essential for neurotransmitter release. A number of previous post-mortem studies show abnormalities of these proteins in schizophrenia (Gabriel et al., 1997; Young et al., 1998; Sokolov et al., 2000; Knable et al., 2004; Ramos-Miguel et al., 2015). Further, these protein appears to interact with antipsychotic treatment (Gil-Pisa et al., 2012).
Connectome Disconnectivity and Cortical Gene Expression in Patients With Schizophrenia
2017, Biological Psychiatry